The CDTI Innovation accelerates biotechnology for health for citizens with support from european funds ERDF 2025

Genomic sequencing of medicine, health biotechnology lives a qualitative leap which translates into more early diagnosis, treatment tailored to each patient and measurable savings clinical. In Spain, this change is occurring faster — and with greater territorial capillarity — thanks to the momentum of Innovation public CDTI and cofinancing of european funds FEDER: a combination that reduces the risk, accelerates the transfer of knowledge and makes laboratory discoveries in solutions that come onto the market and, above all, to the people

Biotecnología en salud
Público-privada collaboration and coordination among government agencies, academia and businesses are vital